Anthropic filed a confidential S-1 with the SEC on June 1, 2026. The company that built Claude, the AI model that can write code for seven hours straight, is going public. Bloomberg confirmed it. The SEC paperwork is in. Goldman Sachs, Morgan Stanley, and JPMorgan are running the roadshow.
That price tag — the S-1 reportedly targeted a $965 billion valuation — puts Anthropic among the most anticipated IPOs since Meta. The problem: IPOs are for institutions and accredited investors. The rest of us wait until the stock hits the exchange and hope the first-day pop hasn’t already priced us out.
Except that’s no longer the whole story.
SEC rules written after the 2012 JOBS Act created a back door. Two exemption pathways — Regulation Crowdfunding (Reg CF) and Regulation A+ — let non-accredited investors buy shares in private companies before they go public. The minimum can be under $50.
Here is how the mechanism actually works, what the SEC allows, what it limits, and what nobody tells you about the risks.
The Two Exemptions That Make Pre-IPO Public Investing Possible
Before 2012, investing in a private company before its IPO meant one thing: being an accredited investor. The SEC defined that as earning $200,000 a year individually or $300,000 jointly, or holding $1 million in net worth excluding your primary residence. About 13% of U.S. households qualify.
The JOBS Act changed that. Congress told the SEC to create rules that let ordinary investors participate in early-stage company funding. The result was two new exemption categories.
Regulation Crowdfunding (Reg CF) — companies can raise up to $5 million per year through SEC-registered online platforms. Anyone can invest. The investments happen through funding portals like Republic, StartEngine, and Wefunder. The SEC requires these platforms to be registered intermediaries, meaning they handle the transaction, the disclosures, and the investor communications.
Regulation A+ (Tier 2) — companies can raise up to $75 million per year. Non-accredited investors can participate, but with a cap: no more than 10% of the greater of their annual income or net worth. Tier 2 requires audited financial statements and ongoing SEC reporting.
The difference matters. Reg CF is capped at $5 million per company per year — pocket change for a company like Anthropic. The real volume happens through Reg A+ and through secondary market structures that exist outside both exemptions.
What the rAnthropic Offering Showed
Republic launched rAnthropic in early 2026 — a Reg CF offering that gave non-accredited investors a way to buy tokenized exposure to Anthropic shares. The offering closed on March 2, 2026. It raised $1.5 million from 1,314 investors.
The mechanics were straightforward. Republic set a share price range of $50-$65, near the secondary market price at the time. Investors committed through Republic’s funding portal, RepublicX LLC, an SEC-registered intermediary. The minimum investment was low — under $50 for some entry tiers.
This was a Reg CF offering, which means the $5 million cap applied. But here is what matters: the tokenized structure meant Republic bought Anthropic shares in the secondary market (from employees or early investors willing to sell) and issued tokenized equivalents to crowdfunding investors. That distinction is critical, because Anthropic itself has stated it does not authorize SPV or tokenized structures for its stock.
The rAnthropic offering closed successfully. But it is closed. No new investors can enter through that specific vehicle.
The Real Investment Limits
The SEC applies specific caps to protect non-accredited investors from overcommitting. The limits apply across all Reg CF offerings in any 12-month period, not per offering.
If your annual income or net worth is below $124,000: you can invest the greater of $2,500 or 5% of the larger figure. If you earn $60,000 and have $40,000 in net worth, your cap is $3,000 (5% of $60,000). If you earn $30,000, your cap is $2,500.
If both your annual income and net worth are $124,000 or above: you can invest 10% of the greater figure, up to a maximum of $124,000 across all Reg CF offerings in a 12-month period. Someone earning $150,000 with $200,000 in net worth can invest up to $15,000.
Reg A+ Tier 2 is simpler: non-accredited investors are capped at 10% of the greater of annual income or net worth per offering. No hard dollar ceiling, but the 10% rule applies. Accredited investors face no caps in either exemption.
Spouses can calculate their limits jointly. The calculation uses the greater of combined annual income or combined net worth. This matters because it effectively doubles the room for married couples in lower brackets.
The One-Year Lockup
Every Reg CF purchase comes with a one-year resale restriction. You cannot sell the shares you bought through crowdfunding for 12 months from the date of purchase. This applies regardless of whether the company IPOs during that period.
The logic: Reg CF securities are not registered with the SEC in the same way exchange-traded stocks are. The one-year holding period ensures the company’s disclosure obligations have time to mature before the shares can trade freely.
This is the most under-discussed risk in the pre-IPO crowdfunding pitch. A company can file its S-1, go public, and see its stock double on day one — and you are locked out of selling for the remainder of your one-year window. The IPO pop is irrelevant if you cannot participate in it.
Anthropic’s timeline complicates this further. The S-1 was filed June 1, 2026. The IPO is targeting October 2026. If you bought rAnthropic tokens in February 2026, you cannot sell until February 2027 — roughly four months after the IPO. The lockup runs from your purchase date, not the IPO date.
How This Compares to Being an Accredited Investor
The accredited investor path is less restricted and more expensive.
Accredited investors can buy Anthropic shares through secondary marketplaces like Forge Global, Hiive, and EquityZen. These platforms connect willing sellers (usually employees with vested shares) with buyers. Minimums are higher — typically $10,000 to $100,000 per position. The share prices track the secondary market, which priced Anthropic around $59 per share as of June 2025.
The key difference: no investment caps, no one-year lockup from purchase (though the company’s own transfer restrictions still apply), and access to a much larger pool of available shares.
The accredited path also avoids the intermediary risk. When you buy through Forge or Hiive, the transaction is typically a direct share transfer approved by the company’s board. When you buy through a Reg CF tokenized structure, you are buying a representation of the share, not the share itself, and your claim depends on the intermediary’s legal structure holding up.
Anthropic has been aggressive about this. The company has stated it does not permit SPVs to acquire its stock and that any transfers to SPVs are void. The company specifically warned that third parties claiming to sell Anthropic shares to the general public through tokenized securities or forward contracts may be offering investments that have no value due to the company’s transfer restrictions.
That warning was aimed directly at the Reg CF tokenized model. The rAnthropic offering priced its tokens near secondary market levels anyway, suggesting the market was pricing in the risk.
The Funds Alternative
Another path exists between crowdfunding and accredited-only access: publicly traded funds that hold Anthropic in their portfolios.
ARK Venture Fund (ARKVX) holds Anthropic as a core position alongside SpaceX, OpenAI, and Stripe. It is available to accredited investors with quarterly liquidity windows. The fund acquired its Anthropic position through board-authorized channels, meaning the equity is recognized on the cap table.
Destiny Tech100 (DXYZ) trades on the NYSE. It holds Anthropic, SpaceX, OpenAI, and other private companies. It is accessible through any standard brokerage account — no accreditation required. The catch: DXYZ has historically traded at a significant premium to its net asset value (NAV), meaning you pay more per dollar of underlying Anthropic exposure than the holding is worth.
The NAV premium is a real cost. If Anthropic goes public at $60 and DXYZ’s NAV reflects that, but DXYZ trades at a 30% premium to NAV, you are effectively paying $78 for $60 worth of exposure. When the IPO happens and investors rotate out of the fund into the direct stock, the premium tends to collapse.
What the Promo Does Not Tell You
Jeff Brown’s Anthropic Master Plan pitch, distributed through Brownstone Research’s The Near Future Report, highlights the pre-IPO opportunity. It frames Reg CF and Reg A+ as the mechanism that lets anyone participate. The numbers get your attention: Facebook produced $1,000 into over $1 million on day one, Uber turned $1,000 into $1.6 million, Google turned $1,000 into $2.3 million.
Those returns are real. They are also retrospective and survivorship-biased. The same pitch could cite Snap (never traded above $60 after its IPO) or Peloton (below $10 after peaking near $170). Pre-IPO investing amplifies both upside and downside because there is no liquid market to exit into.
The Reg CF path is real. The $50 minimum is real. But the mechanism carries risks that the historical IPO pop comparison glosses over. The one-year lockup means you are forced to hold through whatever happens after the IPO. The tokenized structure depends on the intermediary’s legal framework. The company itself has warned that unauthorized transfers will not be recognized.
These are not reasons to sit out. They are reasons to understand what you are buying before you commit.
Where This Leaves You
The JOBS Act created a genuine pathway for non-accredited investors to participate in pre-IPO companies. Reg CF and Reg A+ are real SEC exemptions with real rules, real limits, and real investor protections. The rAnthropic offering proved the mechanism works — 1,314 investors bought in with under $50 minimums.
But the mechanism is not a magic portal to IPO wealth. It is a regulated exemption with limits on the amount you can invest, a one-year lockup on selling, and a legal structure that depends on the intermediary’s compliance with the company’s transfer restrictions.
The smartest approach: understand the limits before you invest. Treat any pre-IPO allocation as a long-term hold regardless of when the IPO happens. Never invest more than the Reg CF cap allows relative to your income and net worth — and that cap exists for a reason.
The pre-IPO door is open wider than it has ever been for non-accredited investors. That is progress. Just do not confuse a lower barrier to entry with a guaranteed outcome.